Is ELXMF or ORCC a better dividend investment in 2026?

ELXMF currently yields 105263.16% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: ELXMF offers higher current income.

What is the dividend yield difference between ELXMF and ORCC?

ELXMF has a forward dividend yield of 105263.16% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 105253.37 percentage points.

Home › Compare › ELXMF vs ORCC

ELXMF vs ORCC: Dividend Comparison 2026

ELXMF yields 105263.16% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ELXMF wins by $8.064713171987811e+26M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ELXMF

● Live price

105263.16%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.064713171987811e+26M

Annual income

$804,966,999,868,734,400,000,000,000,000,000.00

Full ELXMF calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — ELXMF vs ORCC

📍 ELXMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ELXMF	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ELXMF + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ELXMF pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELXMF

Annual income on $10K today (after 15% tax)

$8,947,368.42/yr

After 10yr DRIP, annual income (after tax)

$684,221,949,888,424,200,000,000,000,000,000.00/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, ELXMF beats the other by $684,221,949,888,424,200,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELXMF + ORCC for your $10,000?

ELXMF: 50%ORCC: 50%

100% ORCC50/50100% ELXMF

Portfolio after 10yr

$4.0323565859939053e+26M

Annual income

$402,483,499,934,367,200,000,000,000,000,000.00/yr

Blended yield

99.81%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ELXMF

No analyst data

Altman Z

-1.9

Piotroski

4/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELXMF buys

ORCC buys

No recent congressional trades found for ELXMF or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricELXMFORCC

Forward yield	105263.16% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$8.064713171987811e+26M	$21.4K ✓
Annual income after 10y	$804,966,999,868,734,400,000,000,000,000,000.00 ✓	$1.04
Total dividends collected	$8.063727433132777e+26M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: ELXMF vs ORCC ($10,000, DRIP)

Year	ELXMF Portfolio	ELXMF Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$10,537,016	$10,526,315.79	$11,190	$489.61	+$10.53M → ELXMF
2	$10,377,251,773	$10,365,977,166.23	$12,229	$256.01	+$10377.24M → ELXMF
3	$9,552,044,282,229	$9,540,940,622,831.33	$13,216	$130.74	+$9552044.27M → ELXMF
4	$8,217,919,074,277,338	$8,207,698,386,895,354.00	$14,207	$66.02	+$8217919074.26M → ELXMF
5	$6,608,173,294,209,699,000	$6,599,380,120,800,222,000.00	$15,234	$33.17	+$6608173294209.68M → ELXMF
6	$4,966,582,566,903,309,000,000	$4,959,511,821,478,505,000,000.00	$16,317	$16.62	+$4966582566903309.00M → ELXMF
7	$3,488,939,161,660,980,000,000,000	$3,483,624,918,314,393,500,000,000.00	$17,468	$8.32	+$3488939161660979712.00M → ELXMF
8	$2,290,823,651,613,942,000,000,000,000	$2,287,090,486,710,964,800,000,000,000.00	$18,695	$4.16	+$2.2908236516139422e+21M → ELXMF
9	$1,405,904,046,772,744,300,000,000,000,000	$1,403,452,865,465,517,400,000,000,000,000.00	$20,006	$2.08	+$1.4059040467727442e+24M → ELXMF
10	$806,471,317,198,781,100,000,000,000,000,000	$804,966,999,868,734,400,000,000,000,000,000.00	$21,407	$1.04	+$8.064713171987811e+26M → ELXMF

ELXMF vs ORCC: Complete Analysis 2026

ELXMF — Stock

Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.

Full ELXMF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this ELXMF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELXMF vs SCHD ELXMF vs JEPI ELXMF vs O ELXMF vs KO ELXMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.